Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome P450 3A4 substrate, in patients with chronic myeloid leukaemia. Here, CYP3A4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.